Article Versions Notes

Li J-P, Lin C-W, Huang C-C, Lu Y-T, Ho Y-T, Yang S-F, Hsin C-H. Lipocalin 2 Reduces MET Levels by Inhibiting MEK/ERK Signaling to Inhibit Nasopharyngeal Carcinoma Cell Migration. Cancers. 2022; 14(22):5707. https://doi.org/10.3390/cancers14225707

Li, Ju-Pi, Chiao-Wen Lin, Cheng-Chen Huang, Yen-Ting Lu, Yu-Ting Ho, Shun-Fa Yang, and Chung-Han Hsin. 2022. "Lipocalin 2 Reduces MET Levels by Inhibiting MEK/ERK Signaling to Inhibit Nasopharyngeal Carcinoma Cell Migration" Cancers 14, no. 22: 5707. https://doi.org/10.3390/cancers14225707

Li, J.-P., Lin, C.-W., Huang, C.-C., Lu, Y.-T., Ho, Y.-T., Yang, S.-F., & Hsin, C.-H. (2022). Lipocalin 2 Reduces MET Levels by Inhibiting MEK/ERK Signaling to Inhibit Nasopharyngeal Carcinoma Cell Migration. Cancers, 14(22), 5707. https://doi.org/10.3390/cancers14225707